Asterias Biotherapeutics Inc (AST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,372 | -35,489 | -15,003 | -10,097 | -22,380 |
| Depreciation Amortization | 3,796 | 3,862 | 3,335 | 5,404 | 1,031 |
| Income taxes - deferred | N/A | -2,325 | -7,252 | -7,376 | -3,281 |
| Accounts payable and accrued liabilities | -675 | 329 | -24 | 120 | 567 |
| Other Working Capital | -2,210 | 832 | 2,416 | -1,336 | 5,142 |
| Other Operating Activity | 3,024 | 13,783 | 4,135 | 1,694 | 17,594 |
| Operating Cash Flow | $-24,437 | $-19,008 | $-12,393 | $-11,591 | $-1,327 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,012 | N/A | N/A | 12,661 | N/A |
| PPE Investments | -290 | -894 | -4,592 | -334 | -1,219 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -55 |
| Other Investing Activity | 0 | 31 | -1 | -307 | 0 |
| Investing Cash Flow | $722 | $-863 | $-4,593 | $12,020 | $-1,274 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -489 | -427 | -1 | N/A | N/A |
| Common Stock Issued | 18,425 | 30,669 | 22,068 | 476 | 5,000 |
| Other Financing Activity | -755 | -1,754 | 3,026 | 0 | -228 |
| Financing Cash Flow | $17,181 | $28,488 | $25,093 | $476 | $4,772 |
| Beginning Cash Position | 19,800 | 11,183 | 3,076 | 2,171 | N/A |
| End Cash Position | 13,266 | 19,800 | 11,183 | 3,076 | 2,171 |
| Net Cash Flow | $-6,534 | $8,617 | $8,107 | $905 | $2,171 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,437 | -19,008 | -12,393 | -11,591 | -1,327 |
| Capital Expenditure | -290 | -894 | -4,592 | -334 | -1,247 |
| Free Cash Flow | -24,727 | -19,902 | -16,985 | -11,925 | -2,574 |